InCrowd and Survey Healthcare Global are now part of Konovo

Innovative Mass Spectrometry Research in Oncology Diagnostics


Quantitative and Qualitative Insights from EU5, China, and USA on Advanced Clinical Testing Devices


Konovo’s Mass Spectrometry Oncology Quant and Qual Case Study highlights our expertise in capturing deep insights from both users and non-users of advanced diagnostic devices across global markets. Conducting 150 quantitative interviews in EU5 and 60 qualitative interviews in China and the USA, we engaged lab directors and managers to assess adoption, usability, and perceptions of cutting-edge tools like the iKnife—capable of delivering 89% diagnostic accuracy and 94% positive predictive value in womb cancer detection. Overcoming extremely low incidence rates and market limitations, our adaptive recruitment strategy combined panel outreach, LinkedIn campaigns, referrals, and freelancer networks to exceed client expectations. The result: actionable oncology market intelligence that supports faster, more accurate cancer diagnostics and strengthens strategic product positioning 

Mass-Spectrometry-Oncology-Quant-and-Qual-Case-Study

You may also be interested in:

AI Hand

Harnessing Swarm AI for Breakthrough Healthcare Market Research

Keep Reading

Precision KOL Mapping for Strategic Healthcare Insights

Keep Reading

Driving Brand Success Through Patient-Centered Website Redesign Insights

Keep Reading